articleGastroenterologyMay 18, 2020BRONZE OA

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

EJErica J. BrennerRCRyan C. UngaroRBRichard B. GearryGGGilaad G. KaplanMKMichele Kissous-Hunt

University of North Carolina Health Care · University of North Carolina Hospitals · +13 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

691
total citations
FWCI
110.82
Percentile
100%
References
31
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Medicine
  • Coronavirus disease 2019 (COVID-19)
  • Inflammatory Bowel Diseases
  • Adverse effect
  • Tumor necrosis factor alpha
  • 2019-20 coronavirus outbreak
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Inflammatory bowel disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding